litlas
Log inCreate account

William S. Dalton

Active 1976–2024

106
Papers
26,380
Citations
85
h-index
104
i10-index

Citations

Citations per year for William S. Dalton1948: 1 citations1981: 1 citations1982: 1 citations1986: 3 citations1987: 3 citations1988: 9 citations1989: 18 citations1990: 28 citations1991: 55 citations1992: 48 citations1993: 46 citations1994: 42 citations1995: 83 citations1996: 89 citations1997: 70 citations1998: 60 citations1999: 131 citations2000: 208 citations2001: 242 citations2002: 256 citations2003: 297 citations2004: 246 citations2005: 247 citations2006: 298 citations2007: 313 citations2008: 285 citations2009: 308 citations2010: 315 citations2011: 309 citations2012: 281 citations2013: 349 citations2014: 279 citations2015: 248 citations2016: 237 citations2017: 164 citations2018: 193 citations2019: 530 citations2020: 561 citations2021: 545 citations2022: 317 citations2023: 238 citations2024: 303 citations2025: 135 citations2026: 3 citations1949–1980: no citations, so these years are not shown1983–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,368 citing papers, 33.8% of this breakdownChina: 878 citing papers, 8.8% of this breakdownGermany: 552 citing papers, 5.5% of this breakdownItaly: 488 citing papers, 4.9% of this breakdownUnited Kingdom: 484 citing papers, 4.9% of this breakdownFrance: 376 citing papers, 3.8% of this breakdownNetherlands: 340 citing papers, 3.4% of this breakdownCanada: 329 citing papers, 3.3% of this breakdownJapan: 297 citing papers, 3% of this breakdownSpain: 267 citing papers, 2.7% of this breakdownAustralia: 222 citing papers, 2.2% of this breakdownIndia: 173 citing papers, 1.7% of this breakdown
0%33.8%Other 22%

Institutions

Fields

  • Medicine59.3%
  • Biochemistry, Genetics and Molecular Biology29.9%
  • Immunology and Microbiology5.5%
  • Engineering0.9%
  • Materials Science0.7%
  • Mathematics0.7%
  • Other3%

Topics

  • Multiple Myeloma Research and Treatments5.8%
  • Cytokine Signaling Pathways and Interactions3.7%
  • Drug Transport and Resistance Mechanisms3.4%
  • Protein Degradation and Inhibitors2.9%
  • MicroRNA in disease regulation2.7%
  • Ubiquitin and proteasome pathways2.1%
  • Other79.4%

Coauthors

All papers

Open in search
  1. Environment-mediated drug resistance: a major contributor to minimal residual disease

    Authors: Mark B. Meads, Robert A. Gatenby, William S. Dalton - Nature reviews. Cancer 2009 cited by 864

  2. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

    Authors: Jacob G. Scott, Anders Berglund, Michael J. Schell, I Mihaylov, William J. Fulp, Binglin Yue, Eric A. Welsh, Jimmy J. Caudell, Kamran A. Ahmed, T. Ström, Eric A. Mellon, Puja Venkat, Peter A.S. Johnstone, John A. Foekens, Jae Lee, Eduardo G. Moros, William S. Dalton, Steven A. Eschrich, Howard L. McLeod, Louis B. Harrison, Javier F. Torres–Roca - The Lancet Oncology 2016 cited by 469

  3. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

    Authors: Tianhong Wang, Guilian Niu, Marcin Kortylewski, Lyudmila G. Burdelya, Kenneth H. Shain, Shumin Zhang, Raka Bhattacharya, Dmitry I. Gabrilovich, Richard Heller, Domenico Coppola, William S. Dalton, Richard Jove, Drew M. Pardoll, Hua Yu - Nature Medicine 2003 cited by 1,148

  4. Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

    Authors: Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer, Thierry Façon, Jean‐Luc Harousseau, Dina Ben‐Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesús F. San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, William S. Dalton, Anthony Boral, Dixie Esseltine, Jane Porter, David P. Schenkein, Kenneth C. Anderson - New England Journal of Medicine 2005 cited by 2,493

  5. MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

    Authors: William Kong, Hua Yang, Lili He, Jianjun Zhao, Domenico Coppola, William S. Dalton, Jin Q. Cheng - Molecular and Cellular Biology 2008 cited by 689

  6. Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

    Authors: Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro, James Turkson, Alexander Levitzki, Rocco Savino, Gennaro Ciliberto, Lynn C. Moscinski, José L. Fernández-Luna, Gabriel Núñez, William S. Dalton, Richard Jove - Immunity 1999 cited by 1,651

  7. Optimizing Cancer Treatment Using Game Theory

    Authors: Kateřina Staňková, Joel S. Brown, William S. Dalton, Robert A. Gatenby - JAMA Oncology 2018 cited by 216

  8. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    Authors: Shaji Kumar, J H Lee, Juan José Lahuerta, Gareth J. Morgan, Paul G. Richardson, John Crowley, J. Haessler, J Feather, Antje Hoering, Philippe Moreau, Xavier Leleu, Cyrille Hulin, Saskia K. Klein, Pieter Sonneveld, David S. Siegel, Joan Bladé, Hartmut Goldschmidt, Sundar Jagannath, Jesús F. San Miguel, Robert Z. Orlowski, Antonio Palumbo, Orhan Sezer, S. Vincent Rajkumar, Brian G.M. Durie, on behalf of the International Myeloma Working Group, International Myeloma Working Group, Niels Abildgaard, Rafat Abonour, R. Alexanian, Melissa Alsina, C Anderson Kenneth, Michael Attal, Hervé Avet‐Loiseau, Ashraf Badros, Dalsu Baris, Bart Barlogie, Régis Bataille, Meral Beksaç, Andrew Belch, Dina Ben‐Yehuda, Bill Bensinger, P. Leif Bergsagel, Jenny Bird, Joan Bladé, Mario Boccadoro, Michèle Cavo, Asher Chanan‐Khan, Wen Ming Chen, Tony Child, James Chim, Wee Joo Chng, Ray Comenzo, John Crowley, William S. Dalton, Faith E. Davies, Cármino Antônio De Souza, Michel Delforge, Meletios Α. Dimopoulos, Angela Dispenzieri, Johannes Drach, Matthew T. Drake, Brian G.M. Durie, Hermann Einsele, Theirry Facon, Dorotea Fantl, Jean‐Paul Fermand, Rafaël Fonseca, Gösta Gahrton, Ramón García‐Sánz, Christina Gasparetto, Morie A. Gertz, John Gibson, Sergio Giralt, Hartmut Goldschmidt, Philip R. Greipp, Roman Hájek, Izhar Hardan, Parameswaran Hari, Jean‐Luc Harousseau, Hiroyuki Hata, Yutaka Hattori, Tom Heffner, Joy Ho, Vânia Hungria, Shinsuke Ida, Peter Jacob, Sundar Jagannath, Hans Erik Johnsen, Jian Hou, Douglas Joshua, Artur Jurczyszyn, Michio Kawano, Nicolaus Kröger, Shaji Kumar, Robert A. Kyle, Martha Q. Lacy, Juan José Lahuerta, Ola Landgren, Jacob P. Laubach, Jae Hoon Lee and 60 more - Leukemia 2011 cited by 721

  9. Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

    Authors: Xiaohong Zhao, Tint Lwin, Ariosto Silva, Bijal Shah, Jiangchuan Tao, Bin Fang, Liang Zhang, Kai Fu, Chengfeng Bi, Jiannong Li, Huijuan Jiang, Mark B. Meads, Timothy Jacobson, Maria João Silva, Allison Distler, Lancia Darville, Ling Zhang, Ying Han, Dmitri Rebatchouk, Maurizio Di Liberto, Lynn C. Moscinski, John M. Koomen, William S. Dalton, Kenneth H. Shain, Michael Wang, Eduardo M. Sotomayor, Jianguo Tao, Jianguo Tao, Jianguo Tao - Nature Communications 2017 cited by 148

  10. The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance

    Authors: Mark B. Meads, Lori Hazlehurst, William S. Dalton - Clinical Cancer Research 2008 cited by 520

  11. ABCG2 expression, function, and promoter methylation in human multiple myeloma

    Authors: Joel G. Turner, Jana Gump, Chunchun Zhang, James M. Cook, Douglas C. Marchion, Lori Hazlehurst, Pamela N. Münster, Michael J. Schell, William S. Dalton, Daniel M. Sullivan - Blood 2006 cited by 188

  12. Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines

    Authors: Valerie A. Kickhoefer, Kavitha S. Rajavel, George L. Scheffer, William S. Dalton, Rik J. Scheper, Leonard H. Rome - Journal of Biological Chemistry 1998 cited by 254

  13. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

    Authors: Robert H. Collins, Ofer Shpilberg, William R. Drobyski, David Porter, Sergio Giralt, Richard E. Champlin, Stacey Goodman, S N Wolff, Hu Wh, Catherine M. Verfaillie, Alan F. List, William S. Dalton, Nadine Ognoskie, Angela Chetrit, Joseph H. Antin, John Nemunaitis - Journal of Clinical Oncology 1997 cited by 1,258

  14. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages

    Authors: Jay K. Mandula, Rosa A. Sierra-Mondragon, Rachel V. Jimenez, Darwin Chang, Eslam Mohamed, Shiun Chang, Julio Angel Vázquez-Martínez, Yu Cao, Carmen M. Anadon, Sae Bom Lee, Satyajit Das, Léo Rocha-Munguba, Vincent Pham, Roger Li, Ahmad A. Tarhini, Muhammad Furqan, William S. Dalton, Michelle L. Churchman, Carlos Moran Segura, Jonathan V. Nguyen, Bradford A. Perez, Douglas J. Kojetin, Alyssa Obermayer, Xiaoqing Yu, Ann Chen, Timothy I. Shaw, José R. Conejo-García, Paulo C. Rodrı́guez - Immunity 2024 cited by 32

  15. Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines

    Authors: Jason S. Damiano, Anne E. Cress, Lori Hazlehurst, Аlexander А. Shtil, William S. Dalton - Blood 1999 cited by 865

  16. PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

    Authors: Yuan Ren, Chengfeng Bi, Xiaohong Zhao, Tint Lwin, Cheng Wang, Yuan Ji, Ariosto S. Silva, Bijal Shah, Bin Fang, Tao Li, John M. Koomen, Huijuan Jiang, Julio C. Chávez, Lan V. Pham, Praneeth Sudalagunta, Lixin Wan, Xuefeng Wang, William S. Dalton, Lynn C. Moscinski, Kenneth H. Shain, Julie M. Vose, John L. Cleveland, Eduardo M. Sotomayor, Kai Fu, Jianguo Tao - Journal of Clinical Investigation 2018 cited by 92

  17. Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

    Authors: William R. Friedenberg, Montserrat Rué, Emily Blood, William S. Dalton, Chaim Shustik, Richard A. Larson, Pieter Sonneveld, Philip R. Greipp - Cancer 2006 cited by 163

  18. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells

    Authors: Qing Chen, Pieter C. Van der Sluis, David Boulware, Lori Hazlehurst, William S. Dalton - Blood 2005 cited by 141

  19. Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)

    Authors: Lori Hazlehurst, Jason S. Damiano, I Buyuksal, W. J. Pledger, William S. Dalton - Oncogene 2000 cited by 342

  20. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

    Authors: Gang Niu, Richard Heller, Robyn Catlett-Falcone, Domenico Coppola, Mark J. Jaroszeski, William S. Dalton, Richard Jove, Hua Yu - 1999 cited by 315

  21. Methylation of Discrete Regions of the O 6 -Methylguanine DNA Methyltransferase (MGMT) CpG Island Is Associated with Heterochromatinization of the MGMT Transcription Start Site and Silencing of the Gene

    Authors: George S. Watts, Russell O. Pieper, J Costello, Yei-Mei Peng, William S. Dalton, Bernard W. Futscher - Molecular and Cellular Biology 1997 cited by 218

  22. Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells

    Authors: Terry H. Landowski, Nancy Olashaw, Deepak Agrawal, William S. Dalton - Oncogene 2003 cited by 185

  23. Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow

    Authors: Kelly Boucher, Nancy Parquet, Raymond Widen, Kenneth H. Shain, Rachid Baz, Melissa Alsina, John M. Koomen, Claudio Anasetti, William S. Dalton, Lia Perez - Clinical Cancer Research 2012 cited by 85

  24. Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors

    Authors: Joel G. Turner, Jana L. Dawson, Steven Grant, Kenneth H. Shain, William S. Dalton, Yun Dai, Mark B. Meads, Rachid Baz, Michael Kauffman, Sharon Shacham, Daniel M. Sullivan - Journal of Hematology & Oncology 2016 cited by 84